(Q38185647)

30 August 2017

Myocyte signalling in leucocyte recruitment to the heart (English)

1 reference

30 August 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1

Alessandra Ghigo

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

30 August 2017

2

Irene Franco

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

30 August 2017

3

Fulvio Morello

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

30 August 2017

language of work or name

1 reference

5 February 2014

1 reference

30 August 2017

Cardiovascular Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

270-280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

The role of monocytes and inflammation in the pathophysiology of heart failure

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Cardiokines: recent progress in elucidating the cardiac secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Duality of innate stress responses in cardiac injury, repair, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Calcineurin splicing variant calcineurin Aβ1 improves cardiac function after myocardial infarction without inducing hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cell-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

The coxsackie-adenovirus receptor induces an inflammatory cardiomyopathy independent of viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Cardiomyocyte-targeted overexpression of the coxsackie-adenovirus receptor causes a cardiomyopathy in association with beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Innate immune signaling in cardiac ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Hypoxic stress induces cardiac myocyte-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Signaling effectors underlying pathologic growth and remodeling of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Targeting Toll-like receptors: emerging therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Disruption of phospholipase Cgamma1 signalling attenuates cardiac tumor necrosis factor-alpha expression and improves myocardial function during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal mouse cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF-α expression and improves cardiac function during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Regulation of the inflammatory response in cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Molecular biology and pathogenesis of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

Continuous Glycoprotein-130–Mediated Signal Transducer and Activator of Transcription-3 Activation Promotes Inflammation, Left Ventricular Rupture, and Adverse Outcome in Subacute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU030

21 January 2018

Identifiers

DOI

10.1093/CVR/CVU030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24501328%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference